FDANews
www.fdanews.com/articles/87293-preclinical-costs-reduced-by-new-human-cell-culture-system-from-northern-germany

PRECLINICAL COSTS REDUCED BY NEW HUMAN CELL CULTURE SYSTEM FROM NORTHERN GERMANY

June 2, 2006

The young biotech start up company Primacyt has developed a long-term human hepatocyte culture system that may be used as a biosensor for the analysis of drugs, food additives, and chemicals. The entrepreneur team has developed serum-free long-term culture techniques for hepatocytes. Currently, several other companies are validating this culture technique in a multi-center study.
Innovations Report